Group One Trading’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12K Sell
957
-355
-27% -$455 ﹤0.01% 7199
2025
Q4
$2.01K Sell
1,312
-46
-3% -$80 ﹤0.01% 7550
2025
Q3
$2.32K Sell
1,358
-167
-11% -$531 ﹤0.01% 7860
2025
Q2
$5K Sell
1,525
-265
-15% -$989 ﹤0.01% 7083
2025
Q1
$4.99K Sell
1,790
-2,626
-59% -$17.2K ﹤0.01% 6646
2024
Q4
$76.4K Buy
4,416
+4,391
+17,564% +$75K ﹤0.01% 4740
2024
Q3
$686 Buy
+25
New +$778 ﹤0.01% 6352
2023
Q4
Sell
-239
Closed -$25K 7406
2023
Q3
$43.4K Buy
239
+61
+34% +$16K ﹤0.01% 5233
2023
Q2
$65K Sell
178
-114
-39% -$51.5K ﹤0.01% 5033
2023
Q1
$195K Sell
292
-337
-54% -$299K ﹤0.01% 3698
2022
Q4
$551K Buy
629
+168
+36% +$211K ﹤0.01% 2958
2022
Q3
$507K Sell
461
-165
-26% -$218K ﹤0.01% 3216
2022
Q2
$518K Sell
626
-96
-13% -$98.8K ﹤0.01% 3384
2022
Q1
$1.12M Buy
722
+201
+39% +$271K ﹤0.01% 2970
2021
Q4
$935K Buy
521
+374
+254% +$1M ﹤0.01% 3428
2021
Q3
$486K Sell
147
-308
-68% -$1.08M ﹤0.01% 4215
2021
Q2
$2M Buy
+455
New +$1.8M ﹤0.01% 2647

Other funds holding BNGO

Group One Trading's BNGO Position: Q1 2026 in Review

Group One Trading reduced its Bionano Genomics (BNGO) stake by 27% in Q1 2026, selling an estimated $455 and leaving 957 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #7199.

Group One Trading first reported a position in BNGO in Q2 2021 and has held it in 17 quarters since. The position peaked at $2M in Q2 2021. 32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Group One Trading held 957 shares of Bionano Genomics worth $1.12K as of Q1 2026.
  • Group One Trading sold 355 Bionano Genomics shares in Q1 2026, an estimated $455.
  • Bionano Genomics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7199 holding.
  • Group One Trading first reported a position in Bionano Genomics in Q2 2021 and has held it in 17 quarters since.
  • Group One Trading's Bionano Genomics position peaked at $2M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.